Status:
UNKNOWN
Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C
Lead Sponsor:
Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria
Conditions:
Hepatitis C, Chronic
Personality Disorders in Prison
Eligibility:
All Genders
18-65 years
Brief Summary
Primary objective: Evaluate the prevalence of personality disorders in patients starting treatment for hepatitis C in the prison and determine their influence on the evolution of the disease.
Detailed Description
Secondary objectives: * Describe the management of patients with personality disorders on treatment for hepatitis C in the prison. * Describe the characteristics of patients who discontinue the treat...
Eligibility Criteria
Inclusion
- Patients 18 years of age.
- Patients with expected prison stay beyond the duration of follow-up period of the study.
- Patients with chronic HCV infection and detectable viral load to initiate treatment with standard therapy.
- Patients their written informed consent to participate in the study.
Exclusion
- Patients previously treated with Interferon (IFN) and Ribavirin (RBV).
- Patients can not read or understand a written questionnaire at the discretion of the investigator.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
263 Patients enrolled
Trial Details
Trial ID
NCT01900886
Start Date
December 1 2010
End Date
December 1 2013
Last Update
July 17 2013
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Penitenciario de El Acebuche
Almería, Almeria, Spain, 04071
2
Centro Penitenciario de Badajoz
Badajoz, Badajoz, Spain, 06071
3
Centro Penitenciario El Puerto III
Jerez de la Frontera, Cadiz, Spain, 11500
4
Centro Penitenciario Las Palmas
Las Palmas de Gran Canaria, Canary Islands, Spain, 35017